Lucid Diagnostics to Participate in the Cantor Global Healthcare Conference 2025

Provided By PR Newswire

Last update: Aug 27, 2025

Fireside chat with Chairman & CEO Lishan Aklog, M.D., scheduled for Friday, September 5, at 8:35 AM EDT

NEW YORK, Aug. 27, 2025 /PRNewswire/ -- Lucid Diagnostics Inc. (Nasdaq: LUCD) ("Lucid" or the "Company") a commercial-stage, cancer prevention medical diagnostics company, and subsidiary of PAVmed Inc. (Nasdaq: PAVM) ("PAVmed"), today announced Lishan Aklog, M.D., Lucid's Chairman and Chief Executive Officer will participate in a fireside chat at the Cantor Global Healthcare Conference 2025 in New York, NY, on Friday, September 5, 2025, at 8:35 AM EDT.